Alphapharm Brand of Glipizide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 17 USDMF, 5 CEP/COS, 4 EU WC, 16 NDC API, 19 Listed Suppliers, $ API Reference Price

INTERMEDIATES

8 API Suppliers

8 API Suppliers

FINISHED DOSAGE FORMULATIONS

101 FDF Dossiers, 73 FDA Orange Book, 4 Europe, 4 Australia, 1 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 2.5MG, TABLET, EXTENDED RELEASE;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 5 SPI Pharma, 2 Seqens, 14 DKSH, 3 Jai Radhe Sales, 6 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 32 BASF, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 15 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 45 Controlled & Modified Release, 37 Direct Compression, 35 Disintegrants & Superdisintegrants, 33 Solubilizers, 31 Thickeners and Stabilizers, 29 Lubricants & Glidants, 25 Granulation, 25 Topical, 21 Film Formers & Plasticizers, 21 Co-Processed Excipients, 18 Parenteral, 11 Taste Masking, 9 Emulsifying Agents, 8 Rheology Modifiers, 8 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules

DIGITAL CONTENT

20 NEWS #PharmaBuzz

20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 13 Finished Drug Prices

MARKET PLACE

5 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 2 USP, 13 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 17783 / DOSAGE - TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
GLIPIZIDE(UNII: X7WDT95N5C) (GLIPIZIDE - UNII:X7WDT95N5C)	GLIPIZIDE	10mg

Inactive Ingredients

Ingredient Name	PD-Rx Pharmaceuticals, Inc.	Roerig
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
SILICON DIOXIDE(ETJ7Z6XBU4)
STEARIC ACID(4ELV7Z65AP)

Drug Product Composition: Alphapharm Brand of Glipizide